Adult patients with advanced Burkitt lymphoma have excellent outcomes with intensive immunochemotherapy protocols, according to findings from a large real-word observational study. Data for 264 adults derived from lymphoma registries in six countries showed that most had early normalisation of survival and minimal risk of relapse when treated with rituximab containing dose-intense chemotherapy protocols. The ...
Excellent outcomes seen for Burkitt lymphoma
By Michael Woodhead
12 Feb 2020